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Background
Aldehdyde dehydrogenase-2 (ALDH2) is essential for the
detoxification of ethanol in the liver but also catalyzes vas-
cular bioactivation of nitroglycerin (glycerol trinitrate,
GTN) to its active metabolite nitric oxide (NO), which
causes vasodilation through accumulation of cyclic GMP.
The clinical use of GTN as a vasodilator is hampered by
loss of efficacy after prolonged treatment, and there is
strong evidence that this results from mechanism-based
inactivation of ALDH2 by GTN. The precise mechanism
of the ALDH2/GTN reaction as well as the identity of the
inactivated enzyme species is still elusive.
Methods
To address these issues, we have determined the crystal
structure of an ALDH2 mutant in complex with GTN. In
addition, the 3D structures of a reaction intermediate and
of the GTN-inactivated enzyme were resolved.
Results
GTN is bound to the active site by hydrogen bonds to the
so-called oxyanion hole, to Gln268 to Ser301 and by
hydrophobic interactions. It is held in a position ideal for
the nucleophilic attack of the active site Cys302. After this
nucleophilic attack, a thionitrate is formed and 1,2-glyceryl
dinitrate is released. This thionitrate was observed in the
second crystal structure. It is in a position similar to the
corresponding atoms of GTN and stabilized by hydrogen
bonds to the oxyanion hole. Finally, the structure of the
inactivated enzyme species determined to a resolution of
1.7 Å agrees well with mass spectrometric results, suggest-
ing that exposure to GTN causes in oxidation of the active
site Cys302 to sulfinic acid.
Conclusions
Our results provide important new insights into the com-
plex mechanism of ALDH2-catalyzed GTN bioactivation
and the development of nitrate tolerance.
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